• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯心房颤动患者的抗凝知识:一项横断面研究。

Knowledge of Anticoagulation Among Saudi Patients With Atrial Fibrillation: A Cross-Sectional Study.

作者信息

Alajami Hamdan N, Alshammari Sulaiman A, Al-Dossari Dalal S, Alajmi Abdullah N, Alsaikhan Alanoud S, Alessa Maha S, Alessa Haifa S, Khalaf Alhothaly Saud, Alnami Mohammed I, Atey Tesfay M, Alnajrani Rashid H, Ali Sheraz

机构信息

Pharmaceutical Care Services, King Saud Medical City, Ministry of Health, Riyadh, SAU.

Family and Community Medicine, King Saud University, College of Medicine, Riyadh, SAU.

出版信息

Cureus. 2021 Nov 3;13(11):e19237. doi: 10.7759/cureus.19237. eCollection 2021 Nov.

DOI:10.7759/cureus.19237
PMID:34877214
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8641793/
Abstract

Background Knowledge about oral anticoagulant treatment can impact treatment outcomes in patients with atrial fibrillation. However, evidence is scarce regarding the knowledge of oral anticoagulants among Saudi patients with atrial fibrillation. Hence, this study aimed to assess the level of anticoagulation knowledge among patients with atrial fibrillation taking oral anticoagulants. Methodology A survey using a cross-sectional study design was conducted among patients with a confirmed diagnosis of atrial fibrillation in a tertiary care setting. The Oral Anticoagulation Knowledge Tool (AKT), a 33-item, self-administered questionnaire, was used to assess the knowledge of anticoagulation. Results A total of 290 patients with a median age of 67 years participated in the survey. More than half of those surveyed (56.2%) were females. Overall, 195 (67.2%) patients had an overall adequate anticoagulation knowledge. The median knowledge score of participants on warfarin was significantly higher than those on direct-acting oral anticoagulants ( < 0.001). Only age was found to be a predictor of AKT. Increasing age was associated with fewer odds of adequate AKT. For every one-year increase in age, the knowledge score decreased by 0.08 (95% confidence interval: -0.13 to -0.04). Conclusions This study found significant knowledge gaps among Saudi patients with atrial fibrillation taking oral anticoagulants. Advancing age was inversely associated with oral anticoagulation knowledge.

摘要

背景

关于口服抗凝治疗的知识会影响房颤患者的治疗效果。然而,沙特房颤患者对抗凝剂知识的相关证据却很匮乏。因此,本研究旨在评估服用口服抗凝剂的房颤患者的抗凝知识水平。

方法

在一家三级医疗机构中,对确诊为房颤的患者进行了一项采用横断面研究设计的调查。使用《口服抗凝知识工具》(AKT),这是一份有33个项目的自填式问卷,用于评估抗凝知识。

结果

共有290名中位年龄为67岁的患者参与了调查。超过一半(56.2%)的受访者为女性。总体而言,195名(67.2%)患者的抗凝知识总体充足。参与者对华法林的知识得分显著高于对直接口服抗凝剂的得分(<0.001)。仅发现年龄是AKT的一个预测因素。年龄增长与AKT充足的几率降低相关。年龄每增加一岁,知识得分下降0.08(95%置信区间:-0.13至-0.04)。

结论

本研究发现,沙特服用口服抗凝剂的房颤患者存在明显的知识差距。年龄增长与口服抗凝知识呈负相关。

相似文献

1
Knowledge of Anticoagulation Among Saudi Patients With Atrial Fibrillation: A Cross-Sectional Study.沙特阿拉伯心房颤动患者的抗凝知识:一项横断面研究。
Cureus. 2021 Nov 3;13(11):e19237. doi: 10.7759/cureus.19237. eCollection 2021 Nov.
2
Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study.房颤患者的抗凝依从性及其相关因素:一项横断面研究。
BMJ Open. 2019 Sep 3;9(9):e029974. doi: 10.1136/bmjopen-2019-029974.
3
Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey.心房颤动患者的抗凝知识:一项澳大利亚调查。
Int J Clin Pract. 2018 Mar;72(3):e13072. doi: 10.1111/ijcp.13072. Epub 2018 Feb 19.
4
The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation.心房颤动患者口服抗凝剂预防卒中血栓形成的知识、健康素养与依从性之间的关系。
Cardiovasc Ther. 2017 Dec;35(6). doi: 10.1111/1755-5922.12304. Epub 2017 Sep 25.
5
Adherence, knowledge, and perception about oral anticoagulants in patients with atrial fibrillation at high risk for thromboembolic events after radiofrequency ablation.在射频消融术后有发生血栓栓塞事件高风险的房颤患者中,关于口服抗凝剂的依从性、知识和认知。
J Adv Nurs. 2018 Nov;74(11):2577-2587. doi: 10.1111/jan.13780. Epub 2018 Aug 30.
6
Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service-a cross-sectional study of patients in a Canadian Health Region.在一家专门的血栓形成治疗机构中,自我报告的直接口服抗凝剂与华法林治疗的依从性——对加拿大一个健康区域患者的横断面研究
Eur J Clin Pharmacol. 2023 Jan;79(1):117-125. doi: 10.1007/s00228-022-03418-8. Epub 2022 Nov 18.
7
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.种族/民族与心房颤动患者口服抗凝药物使用的相关性:来自更好地了解心房颤动治疗的结果登记 II 研究的结果。
JAMA Cardiol. 2018 Dec 1;3(12):1174-1182. doi: 10.1001/jamacardio.2018.3945.
8
Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System.在退伍军人健康管理系统中,不同种族/族裔的患者在接受抗凝治疗治疗新发心房颤动方面存在差异。
JAMA Netw Open. 2021 Jul 1;4(7):e2114234. doi: 10.1001/jamanetworkopen.2021.14234.
9
The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation.老年人房颤患者口服抗凝剂的急性肾损伤风险。
Clin J Am Soc Nephrol. 2021 Oct;16(10):1470-1479. doi: 10.2215/CJN.05920421. Epub 2021 Aug 18.
10
SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.SUPPORT-AF II:通过心房颤动口服抗凝治疗的医疗服务提供者概况分析来支持抗凝剂的使用:一项关于电子概况分析和信息传递联合学术指导的群组随机研究,用于指导医疗服务提供者对心房颤动患者进行抗凝决策。
Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e005871. doi: 10.1161/CIRCOUTCOMES.119.005871. Epub 2020 Feb 17.

引用本文的文献

1
Unlocking Urban India's Awareness of Oral Anticoagulation: Implications for Healthcare Education.开启印度城市居民对抗凝药物的认知:对医疗保健教育的启示
Turk J Pharm Sci. 2025 Mar 7;22(1):19-25. doi: 10.4274/tjps.galenos.2024.80069.
2
Clinical Care Pathway and Management of Major Bleeding Associated with Nonvitamin K Antagonist Oral Anticoagulants: A Modified Delphi Consensus from Saudi Arabia and UAE.非维生素K拮抗剂口服抗凝剂相关严重出血的临床护理路径与管理:沙特阿拉伯和阿联酋的改良德尔菲共识
Mediterr J Hematol Infect Dis. 2024 May 1;16(1):e2024038. doi: 10.4084/MJHID.2024.038. eCollection 2024.
3
Knowledge, Adherence, and Satisfaction With Warfarin Therapy and Associated Factors Among Outpatients at University Teaching Hospital in Ethiopia.

本文引用的文献

1
Are patients on oral anticoagulation therapy aware of its effects? A cross-sectional study from Karachi, Pakistan.口服抗凝治疗患者知晓其作用吗?来自巴基斯坦卡拉奇的一项横断面研究。
BMC Res Notes. 2020 Jun 9;13(1):279. doi: 10.1186/s13104-020-05119-w.
2
Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey.心房颤动患者的抗凝知识:一项澳大利亚调查。
Int J Clin Pract. 2018 Mar;72(3):e13072. doi: 10.1111/ijcp.13072. Epub 2018 Feb 19.
3
The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation.
在埃塞俄比亚的大学教学医院,门诊患者对华法林治疗的知识、依从性和满意度及其相关因素。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241260736. doi: 10.1177/10760296241260736.
4
Position Statement on In-hospital/Clinic Point-of-care Coagulation Testing for Anticoagulation Monitoring in Saudi Arabia.沙特阿拉伯关于医院/诊所即时凝血检测用于抗凝监测的立场声明。
J Saudi Heart Assoc. 2023 Nov 6;35(4):290-300. doi: 10.37616/2212-5043.1355. eCollection 2023.
5
Knowledge and medication adherence of oral anticoagulant-taking patients in Vietnam.越南口服抗凝剂服用患者的知识水平与用药依从性
Res Pract Thromb Haemost. 2023 Jan 11;7(1):100044. doi: 10.1016/j.rpth.2023.100044. eCollection 2023 Jan.
6
Cost effectiveness of rivaroxaban versus warfarin among nonvalvular atrial fibrillation patients in Saudi Arabia: A Single-Center retrospective cohort study.利伐沙班与华法林在沙特阿拉伯非瓣膜性心房颤动患者中的成本效益:一项单中心回顾性队列研究。
Saudi Pharm J. 2023 Jan;31(1):119-124. doi: 10.1016/j.jsps.2022.11.010. Epub 2022 Nov 18.
心房颤动患者口服抗凝剂预防卒中血栓形成的知识、健康素养与依从性之间的关系。
Cardiovasc Ther. 2017 Dec;35(6). doi: 10.1111/1755-5922.12304. Epub 2017 Sep 25.
4
Partnering with patients in shared decision-making for stroke prevention in atrial fibrillation.在房颤卒中预防的共同决策中与患者合作。
Eur J Cardiovasc Nurs. 2017 Mar;16(3):178-180. doi: 10.1177/1474515116685193. Epub 2016 Dec 19.
5
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Eur J Cardiothorac Surg. 2016 Nov;50(5):e1-e88. doi: 10.1093/ejcts/ezw313. Epub 2016 Sep 23.
6
Development and Validation of an Oral Anticoagulation Knowledge Tool (AKT).口服抗凝知识工具(AKT)的开发与验证
PLoS One. 2016 Jun 28;11(6):e0158071. doi: 10.1371/journal.pone.0158071. eCollection 2016.
7
Evaluation of knowledge of Health care professionals on warfarin interactions with drug and herb medicinal in Central Saudi Arabia.沙特阿拉伯中部医疗保健专业人员对华法林与药物和草药相互作用的知识评估。
Pak J Med Sci. 2016 Jan-Feb;32(1):229-33. doi: 10.12669/pjms.321.8902.
8
New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events.新型口服抗凝药:与维生素K拮抗剂相比,它们在预防和治疗血栓栓塞事件患者中的优缺点。
Ther Clin Risk Manag. 2015 Jun 24;11:967-77. doi: 10.2147/TCRM.S84210. eCollection 2015.
9
Lacunae in patient knowledge about oral anticoagulant treatment: results of a questionnaire survey.患者对抗凝治疗认知的空白:一项问卷调查结果
Indian J Hematol Blood Transfus. 2015 Jun;31(2):275-80. doi: 10.1007/s12288-014-0415-z. Epub 2014 Jun 13.
10
Saudi Atrial Fibrillation Survey: national, observational, cross-sectional survey evaluating atrial fibrillation management and the cardiovascular risk profile of patients with atrial fibrillation.沙特房颤调查:一项全国性、观察性、横断面调查,旨在评估房颤患者的房颤管理和心血管风险特征。
Angiology. 2015 Mar;66(3):244-8. doi: 10.1177/0003319714529180. Epub 2014 Mar 31.